These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 29510883)
1. The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system? Haass-Koffler CL Alcohol; 2018 Nov; 72():3-8. PubMed ID: 29510883 [TBL] [Abstract][Full Text] [Related]
2. Defining the role of corticotropin releasing factor binding protein in alcohol consumption. Haass-Koffler CL; Henry AT; Melkus G; Simms JA; Naemmuddin M; Nielsen CK; Lasek AW; Magill M; Schwandt ML; Momenan R; Hodgkinson CA; Bartlett SE; Swift RM; Bonci A; Leggio L Transl Psychiatry; 2016 Nov; 6(11):e953. PubMed ID: 27845775 [TBL] [Abstract][Full Text] [Related]
3. Development and use of a high-throughput screen to identify novel modulators of the corticotropin releasing factor binding protein. Haass-Koffler CL; Francis TC; Gandhi P; Patel R; Naemuddin M; Nielsen CK; Bartlett SE; Bonci A; Vasile S; Hood BL; Suyama E; Hedrick MP; Smith LH; Limpert AS; Roberto M; Cosford NDP; Sheffler DJ SLAS Discov; 2022 Dec; 27(8):448-459. PubMed ID: 36210051 [TBL] [Abstract][Full Text] [Related]
4. A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists. Eckart K; Jahn O; Radulovic J; Tezval H; van Werven L; Spiess J Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11142-7. PubMed ID: 11572971 [TBL] [Abstract][Full Text] [Related]
6. Corticotropin Releasing Factor Binding Protein as a Novel Target to Restore Brain Homeostasis: Lessons Learned From Alcohol Use Disorder Research. Curley DE; Webb AE; Sheffler DJ; Haass-Koffler CL Front Behav Neurosci; 2021; 15():786855. PubMed ID: 34912198 [TBL] [Abstract][Full Text] [Related]
7. The binding protein of corticotropin-releasing factor: ligand-binding site and subunit structure. Jahn O; Eckart K; Brauns O; Tezval H; Spiess J Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12055-60. PubMed ID: 12215497 [TBL] [Abstract][Full Text] [Related]
8. Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Ribbe K; Ackermann V; Schwitulla J; Begemann M; Papiol S; Grube S; Sperling S; Friedrichs H; Jahn O; Sillaber I; Gefeller O; Krampe H; Ehrenreich H Arch Gen Psychiatry; 2011 Dec; 68(12):1247-56. PubMed ID: 21810631 [TBL] [Abstract][Full Text] [Related]
9. Corticotropin Releasing Factor Binding Protein and CRF2 Receptors in the Ventral Tegmental Area: Modulation of Ethanol Binge Drinking in C57BL/6J Mice. Albrechet-Souza L; Hwa LS; Han X; Zhang EY; DeBold JF; Miczek KA Alcohol Clin Exp Res; 2015 Sep; 39(9):1609-18. PubMed ID: 26247973 [TBL] [Abstract][Full Text] [Related]
10. Sequences, expression patterns and regulation of the corticotropin-releasing factor system in a teleost. Chen CC; Fernald RD Gen Comp Endocrinol; 2008 Jun; 157(2):148-55. PubMed ID: 18501902 [TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing factor-binding protein: origins and possible functions. Petraglia F; Florio P; Gallo R; Salvestroni C; Lombardo M; Genazzani AD; Di Carlo C; Stomati M; D'Ambrogio G; Artini PG Horm Res; 1996; 45(3-5):187-91. PubMed ID: 8964581 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of recombinant rat corticotropin releasing factor binding protein using different sauvagine analogs. Jahn O; Eckart K; Sydow S; Hofmann BA; Spiess J Peptides; 2001 Jan; 22(1):47-56. PubMed ID: 11179597 [TBL] [Abstract][Full Text] [Related]
13. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. Lowery EG; Thiele TE CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):77-86. PubMed ID: 20201818 [TBL] [Abstract][Full Text] [Related]
14. The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target? Pomrenze MB; Fetterly TL; Winder DG; Messing RO Alcohol Clin Exp Res; 2017 Dec; 41(12):1986-1999. PubMed ID: 28940382 [TBL] [Abstract][Full Text] [Related]
15. Contribution of Urocortin to the Development of Excessive Drinking. Ryabinin AE; Giardino WJ Int Rev Neurobiol; 2017; 136():275-291. PubMed ID: 29056154 [TBL] [Abstract][Full Text] [Related]
16. Neurobiological mechanisms contributing to alcohol-stress-anxiety interactions. Silberman Y; Bajo M; Chappell AM; Christian DT; Cruz M; Diaz MR; Kash T; Lack AK; Messing RO; Siggins GR; Winder D; Roberto M; McCool BA; Weiner JL Alcohol; 2009 Nov; 43(7):509-19. PubMed ID: 19913194 [TBL] [Abstract][Full Text] [Related]